Archive for October, 2009

Biologic data exclusivity: The arguments for and against it

With the issue of data exclusivity for novel biologics re-emerging in the news, I’d like to present two arguments that will be published in the upcoming issue of the Journal of Commercial Biotechnology: Why data exclusivity is the new patent protection Peter J Pitts, Center for medicine in the public interest Follow-on biologic drug competition […]

Kyoto Prize Journalism Fellowship

I am honored to have been selected for the 2009 Kyoto Prize Journalism Fellowship, offered by Point Loma Nazarene University. This fellowship will allow me to attend the Kyoto Prize Ceremony, laureate lectures and workshops, and associated functions. The Kyoto Prize is one of the world’s most prestigious awards given to those who have made […]

Drug Patent Expirations in October 2009

Courtesy of Drug Patent Expirations in October 2009 Tradename Applicant Generic Name Patent Number Patent Expiration BREATHTEK UBT FOR H-PYLORI Otsuka America urea, c-13 4,830,010 Oct 27, 2009 CEDAX Sciele Pharma Inc ceftibuten dihydrate 4,634,697 Oct 1, 2009 COLGATE TOTAL Colgate Palmolive sodium fluoride; triclosan 5,156,835 Oct 20, 2009 COVERA-HS Gd Searle Llc verapamil […]

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: